Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
A Phase 3 Placebo-Controlled Trial of Once-Daily 400-mg and 600-mg SPN-812 (Viloxazine Extended- Release) in Adolescents with ADHD (OPEN ACCESS)
1
x
$
0.00
Developing an IV Ketamine Clinic for Treatment-Resistant Depression: a Primer
1
x
$
30.00
Consequences of 1,4-Butanediol Misuse: A Review
1
x
$
30.00
Early Positive Report of Viloxazine for a Child with Hyperkinetic Autism
1
x
$
30.00
Correlation of 1846G>A Polymorphism of CYP2D6 Gene with Haloperidol Efficacy and Safety in Patients with Alcoholic Hallucinoses
1
x
$
30.00
The Red Book of Mood Disorders in Women: An Evidence-Based Treatment Guide
1
x
$
30.00
Ralph Ryback, MD: Bioelectrical Modulators and the Cell Membrane in Psychiatric Medicine
1
x
$
30.00
Neurociencias: Estudios poblacionales de la relación entre el traumatismo craneoencefálico y la psiquiatría
1
x
$
0.00
MDMA to Treat PTSD in Adults
1
x
$
30.00
Developing and Testing Adaptive Treatment Strategies Using Substance-Induced Psychosis as an Example
1
x
$
30.00
VOL 2 No. 6 Full Issue - June 2000
1
x
$
20.00
View Cart
Checkout
Home
Store
“VOL 2 No. 6 Full Issue – June 2000” has been added to your cart.
View cart
Sort by
Price
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Establishing a ‘Gateway’ for Patients with Anxiety
$
0.00
Add to cart
Details
WHEN BIGGER IS BETTER: Necessity as the Mother of Medical Invention
$
0.00
Add to cart
Details
Ethical Issues In Schizophrenia: Considerations for Treatment and Research
$
0.00
Add to cart
Details
Neuropsychiatric Update: Neuroimaging Schizophrenia
$
0.00
Add to cart
Details
Genetics of Schizophrenia: Recent Advances
$
0.00
Add to cart
Details
Gender and Schizophrenia
$
0.00
Add to cart
Details
Efficacy of Combined Pharmacological and Cognitive- Behavioral Treatments For Anxiety Disorders
$
0.00
Add to cart
Details
Psychiatric Bulletin: Late-Breaking Clinical News
$
0.00
Add to cart
Details
The MentalFitness Interview: David Shaffer, FRCP, FRCPsych, on the Rise and Fall of the Teen Suicide Rate
$
0.00
Add to cart
Details
Cause & Effect: Dealing with the Loss of a Spouse
$
0.00
Add to cart
Details
Anxiety Disorders: Vast Progress but a Long Journey Ahead
$
0.00
Add to cart
Details
Economic Impacts of Anxiety Disorders
$
0.00
Add to cart
Details
Panic Disorder During Pregnancy
$
0.00
Add to cart
Details
Recognition and Treatment of Anxiety Disorders in Primary Care
$
0.00
Add to cart
Details
Anxiety and Other Emotional Factors in Noncardiac Chest Pain
$
0.00
Add to cart
Details
Does Isotretinoin Cause Depression and Suicide? By J. Douglas Bremner, MD
$
0.00
Add to cart
Details
Nota del Director Editorial: En vivo desde Nueva York, les presentamos Psiquiatría y Salud Integral
$
0.00
Add to cart
Details
Dr. Juan E. Mezzich y Dr. Miguel R. Jorge: ¡Bienvenidos a Psiquiatría y Salud Integral!
$
0.00
Add to cart
Details
Psiquiatría y Salud Integral: El consejo editorial de PSI incluye los siguientes psiquiatras y médicos:
$
0.00
Add to cart
Details
Utilización del nombre de los fármacos
$
0.00
Add to cart
Details
1
2
…
44
Next
Page load link
Go to Top
